+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cataplexy Drug"

From
From
Narcolepsy Drugs Market 2024-2028 - Product Thumbnail Image

Narcolepsy Drugs Market 2024-2028

  • Report
  • July 2024
  • 133 Pages
  • Global
From
Cataplexy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cataplexy - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cataplexy - Pipeline Insight, 2024 - Product Thumbnail Image

Cataplexy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Cataplexy drugs are a type of central nervous system (CNS) drug used to treat cataplexy, a sudden loss of muscle tone caused by strong emotions. These drugs are typically prescribed to people with narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden, uncontrollable episodes of sleep. Cataplexy drugs work by increasing the levels of certain neurotransmitters in the brain, such as serotonin and norepinephrine, which help regulate mood and alertness. Commonly prescribed cataplexy drugs include modafinil, sodium oxybate, and venlafaxine. Some of the major companies in the cataplexy drug market include Cephalon, Inc., Jazz Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. Show Less Read more